The Women’s Professional Baseball League has chosen New York, Boston, Los Angeles and San Francisco as the cities that will represent the four teams that will compete in the inaugural ...

A British woman has avoided execution for drug smuggling in Indonesia under an agreement between the two countries. Lindsay Sandiford, 68, has been imprisoned in Bali since 2012 after being ...

Wasted food is a financial and environmental bummer. It costs the average person $728 per year, and it amounts to about the same planet-warming greenhouse gas emissions every year as ...

When Pennsylvania voters head to the polls on Nov. 4, they’ll weigh in on the future of the state’s highest court.

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 ...

The Tapo C615F KIT’s 2K 3MP clarity camera and 800-lumen dimmable floodlight offers crystal clear coverage over the areas that matter most to homeowners. Optimized day/night exposure, together with ...

B Lab is the independent third party that certifies companies as B Corporations when they meet high standards of social and environmental performance, accountability, and transparency. B Lab certified ...

( Orpyx) announced the addition of Dr. David Shulkin, the Ninth Secretary of the U.S. Department of Veterans Affairs (VA), to its advisory board. Secretary Shulkin brings unmatched expertise in policy ...

Accenture today announced an expansion of its collaboration with Amazon Web Services (AWS) to deliver transformative digital ...

The NBA season opens Tuesday with a record 135 players born outside the U.S. They come from 43 countries, with 71 players from Europe. The NBA is in talks with ...

The blue medical tent has become synonymous with football injuries since the NFL first added it to sidelines in 2017. Fans in the stands and watching on television immediately know ...

As part of the Phase 1/1b IAM1363-01 study, Iambic will initiate a cohort in patients with HER2-positive breast cancer to evaluate IAM1363 in combination with zanidatamab and capecitabine.